Graves' disease and hyperthyroidism trials in South Korea

2 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

  Where

  Daegu, Goyang, Guri-si, Seoul

  Age

  18 years to 75 years

  People

  210 worldwide

  Run by

  Immunovant Sciences GmbH

  See details and how to joinNCT07018323 · EU 2025-521920-31-00
• Phase 2Enrolling by invitation
  A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)

  Where

  Daegu, Gyeonggi-do

  Age

  18 years and over

  People

  372 worldwide

  Run by

  Immunovant Sciences GmbH

  See details and how to joinNCT07286006